Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Schwab US Largecap Value ETF | SCHV | Nov 27, 2024 | 28.01 | 0.00 |
Schwab US Midcap ETF | SCHM | Nov 27, 2024 | 29.89 | -0.30 |
Schwab US REIT ETF | SCHH | Nov 27, 2024 | 23.26 | +0.65 |
Schwab US Smallcap ETF | SCHA | Nov 27, 2024 | 28.12 | +0.04 |
Schwab US Tips ETF | SCHP | Nov 27, 2024 | 26.34 | +0.30 |
Schweitzer-Mauduit International | MATV | Nov 27, 2024 | 13.53 | +0.37 |
Science Applications International | SAIC | Nov 27, 2024 | 123.29 | -0.58 |
Scienjoy A | SJ | Nov 27, 2024 | 0.94 | +2.17 |
Scienture Holdings | SCNX | Nov 27, 2024 | 7.81 | 0.00 |
Scilex | SCLX | Nov 27, 2024 | 0.61 | -3.92 |
Scinai Immunotherapeutics | SCNI | Nov 27, 2024 | 3.46 | -0.57 |
Scisparc | SPRC | Nov 27, 2024 | 0.22 | -2.69 |
Scorpio Tankers | STNG | Nov 27, 2024 | 50.69 | -1.02 |
Scotts Miracle-Gro | SMG | Nov 27, 2024 | 75.80 | -2.57 |
scPharmaceuticals | SCPH | Nov 27, 2024 | 3.74 | +3.89 |
Screaming Eagle Acquisition Unit | SCRMU | Nov 27, 2024 | 10.00 | 0.00 |
Scully Royalty | SRL | Nov 27, 2024 | 7.29 | +0.69 |
SCWorx | WORX | Nov 27, 2024 | 2.58 | +8.40 |
SCYNEXIS | SCYX | Nov 27, 2024 | 1.37 | +8.73 |
SDCL EDGE Acquisition | SEDA | Nov 27, 2024 | 11.30 | 0.00 |
Sea ADR A | SE | Nov 27, 2024 | 115.71 | +1.56 |
Seaboard | SEB | Nov 27, 2024 | 2 639.89 | +0.76 |
Seabridge Gold | SA | Nov 27, 2024 | 14.34 | +0.70 |
Seacoast Banking Corp of Florida | SBCF | Nov 27, 2024 | 30.28 | -0.30 |
SEACOR Marine | SMHI | Nov 27, 2024 | 6.82 | 0.00 |
Seadrill | SDRL | Nov 27, 2024 | 40.23 | +0.90 |
Seagate Technology | STX | Nov 27, 2024 | 100.00 | -1.63 |
Sealed Air | SEE | Nov 27, 2024 | 36.24 | +0.81 |
SEALSQ | LAES | Nov 27, 2024 | 0.41 | -9.31 |
Seanergy Maritime | SHIP | Nov 27, 2024 | 8.13 | +0.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.